Dr. William Hearl receives the 2016 TEDCO ICE Award

TEDCO Accolades

ITI wins TEDCO ICE award for corporate excellence and is featured as the success story in TEDCO's 2015 annual report.

Drs. William Hearl and Teri Heiland

ITI wins "Life Science Company of the Year"

Immunomic Therapeutics, Inc. is the proud recipient of Tech Council of MD's "Life Science Company of the Year". Celebrated at the Industry Awards, it is the only awards ceremony that honors the best in Maryland’s life science and technology community. This celebration is one of Maryland’s largest and most prestigious award ceremonies and recognizes executives, businesses, and innovative technology developed in Maryland and the surrounding regions.

Dr. Duane Mitchell, currently leading research studies at the University of Florida with his mRNA transfected DC vaccine that codes for pp65 and LAMP for people that suffer from Glioblastoma, received Top 10 Clinical Research Achievement Awards recognition for their ATTAC clinical trial.

ITI is looking forward to the ATTAC II trial results, which include testing full-length LAMP!

Upcoming Events

Oct 2-4, 2016 | Boston, MA

ISV Summit

Nov 9-13 | National Harbor, DC


Nov 11-13 | Middleburg, VA

INOVA Summit

Dec 1-2, 2016 | New York, NY

Life Sciences Summit

Dec 7-9, 2016 | Boston, MA

Immunization and Vaccine Summit

We Work For Health

"We Work for Health" partnering with ITI

We Work For Health is a grassroots initiative that shows how biopharmaceutical research and medical innovation work together to create a strong, vibrant economy and a healthier America. We unite biopharmaceutical companies with business and community partners to raise awareness about the vital role we all play in delivering life-saving and life-enhancing advancements in medicine, while educating elected leaders on the impact that public policies have on our ability to continue to innovate.

 LAMP Tech Advantages

LAMP-Vax™, a new approach to DNA vaccines - Competitive Advantages
 For Investors

A brief company update for investors
 Clinical Results

Impressive Clinical Results from our Phase IA & IB Studies